Speakers

More speakers are being announced each week through August and September.

Anthony L. Back, MD Anthony L. Back, MD Professor of Oncology University of Washington, Seattle
Kevin Balktick Kevin Balktick Founder + Director Horizons Media, Inc.
Ritu S. Baral Ritu S. Baral Managing Director & Sr. Biotechnology Analyst TD Cowen
Myriam Barthes Myriam Barthes CEO and Co-Founder Journey Clinical
Andrea Beckel-Mitchener, PhD Andrea Beckel-Mitchener, PhD Acting Director, National Institute of Mental Health National Institutes of Health
Al Bugazia, MD Al Bugazia, MD Deputy Director, Proactive Health ARPA-H
A.J. Cannon, MD A.J. Cannon, MD Medical Director, Neuroscience Clinical Development AbbVie
Maj. Gen. Glenn H. Curtis (Ret.) Maj. Gen. Glenn H. Curtis (Ret.) Ambassador Americans for Ibogaine
Lori Englebert Lori Englebert Chief Commercial Officer Compass Pathways
Gisele Fernandes-Osterhold, LMFT Gisele Fernandes-Osterhold, LMFT Director of Psychedelic Facilitation, TrPR Program University of California San Francisco (UCSF)
Albert Garcia-Romeu, PhD Albert Garcia-Romeu, PhD Johns Hopkins University School of Medicine
Manesh Girn, PhD Manesh Girn, PhD Postdoctoral Neuroscientist University of California, San Francisco
Jazz Glastra Jazz Glastra Senior Director BrainFutures
Guy Goodwin, MD Guy Goodwin, MD Chief Medical Officer Compass Pathways
Andrew Gradison, JD Andrew Gradison, JD Senior Advisor, Veterans Health Administration U.S. Department of Veterans Affairs
Harry Grammer, PhD Harry Grammer, PhD Founder New Earth
Josh Hardman Josh Hardman Founder & Editor Psychedelic Alpha
Rikki Harris Rikki Harris CEO TN Voices
Julie Holland, MD Julie Holland, MD Psychiatrist Private practice, New York City
Bryan Hubbard Bryan Hubbard CEO Americans for Ibogaine
Edny Inui, PhD, MBA Edny Inui, PhD, MBA Partner Palo Santo
Daniel R. Karlin, MD, MA Daniel R. Karlin, MD, MA Chief Medical Officer Definium Therapeutics
Bia Labate, PhD Bia Labate, PhD Executive Director Chacruna Institute
Amy Lehrner, PhD Amy Lehrner, PhD Assistant Professor of Psychiatry Icahn School of Medicine at Mount Sinai
Alberto “Nachi” López Pérez Alberto “Nachi” López Pérez Board Member and Huachuma Conservation Center Director Colectivo Huachuma
Valentina Mantua, MD, PhD Valentina Mantua, MD, PhD Associate Director for Regulatory Science U.S. Food and Drug Administration
Kate Reynolds, MPH Kate Reynolds, MPH Director of Research Rocky Mountain Poison & Drug Safety
Kim Roddy, MBA Kim Roddy, MBA Chief Operating Officer, Co-Founder Sunstone Therapies
Dalibor Sames Dalibor Sames Professor of Chemistry Columbia University
William M. Sauve, MD William M. Sauve, MD Chief Medical Officer Osmind
Erin Schumaker Erin Schumaker Deputy Health Care Editor Politico
Tanya Brara Shah Tanya Brara Shah Strategic Advisor Psychedelic Mental Health Access Alliance
Laurel Anne Sugden Laurel Anne Sugden Co-founder and Executive Director Collective Huachuma
Connor Williams Connor Williams Senior Research Analyst RTW Investments
Rachel Yehuda, PhD Rachel Yehuda, PhD Chemers Neustein Family Professor of Trauma and Resilience Icahn School of Medicine at Mount Sinai
Ariana Zepeda, LCSW Ariana Zepeda, LCSW Deputy Director New Earth
Matthew Zorn, JD Matthew Zorn, JD Deputy General Counsel U.S. Department of Health and Human Services